Used primarily as an intermediate in the synthesis of carbonic anhydrase inhibitors, this compound plays a key role in the development of pharmaceuticals targeting glaucoma and certain types of epilepsy. Its structure supports strong enzyme inhibition activity, making it valuable in medicinal chemistry for designing drugs that regulate fluid balance and intraocular pressure. Additionally, it serves in research settings to explore enzyme mechanisms and structure-activity relationships in sulfonamide-based therapeutics.